6533b7d9fe1ef96bd126cb16

RESEARCH PRODUCT

TCT-43 First-in-human experience of a novel transradial device for embolic deflection during transcatheter aortic valve replacement

Nikos WernerInga NarbuteFrank D. KolodgieUlrich SchäferDarren MylotteAndrejs ĒRglisRobert ZivadinovRenu VirmaniAntoinette Neylon

subject

Stroke ratemedicine.medical_specialtyTranscatheter aorticValve replacementDeflection (engineering)business.industrymedicine.medical_treatmentInternal medicineCardiologyMedicineFirst in humanCardiology and Cardiovascular Medicinebusiness

description

The average stroke rate in contemporary transcatheter aortic valve replacement (TAVR) studies is 4.4%. The majority of the TAVR studies are non-randomized registries, hence, neurological outcomes may be underreported. Over 50% of all TAVR related strokes occur during the procedure or on the same day

yearjournalcountryeditionlanguage
2018-09-01Journal of the American College of Cardiology
https://doi.org/10.1016/j.jacc.2018.08.1127